The grant holders (QL and LW) contributed to the work solely in their capacity as investigators and co-authors, independent of the funders
use as directed and do not exceed the recommended serving.*
Artificial intelligence, computational modeling, and biotechnology innovations are expected to accelerate this progress, helping researchers identify and evaluate new peptide candidates more efficiently than ever before
Retatrutide is an investigational triple agonist (GLP-1, GIP, glucagon receptors) not yet licensed by the MHRA or EMA in the UK
Effectors with chitinase activity (EWCAs), a family of conserved, secreted fungal chitinases that suppress chitin-triggered immunity
Patient safety is our top priority and no medicine would be approved unless it met our expected standards of safety, quality and effectiveness, the spokesperson said